<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01597115</url>
  </required_header>
  <id_info>
    <org_study_id>DUPLEX-IV-02-12</org_study_id>
    <nct_id>NCT01597115</nct_id>
  </id_info>
  <brief_title>ENhancing Maturation of Autogenous Arteriovenous Hemodialysis Access by Aggressive surveillaNCe With Duplex and Endovascular Treatment</brief_title>
  <acronym>ENHANCE</acronym>
  <official_title>ENhancing Maturation of Autogenous Arteriovenous Hemodialysis Access by Aggressive surveillaNCe With Duplex and Endovascular Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate whether Aggressive duplex surveillance after vascular
      access surgery with native vein for hemodialysis can increase the maturation rate of
      arteriovenous fistula. This study will be conducted as a single center, prospective, 1:1
      randomized study. Enrolled patients will be randomized as a control group (Physical exam at 2
      and 4 weeks after surgery) and duplex group (duplex study and physical exam at 2 and 4 weeks
      after surgery). Maturation of arteriovenous fistula will be evaluated at 8 weeks after
      surgery by duplex in all patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>hemodialysis access maturation rate</measure>
    <time_frame>8 weeks after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>factors predicting maturation failure</measure>
    <time_frame>8 weeks after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>Duplex</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group will be examed by duplex ultrasonography at 2 and 4 weeks after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>physical exam</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>According to the K/DOQI guideline, patients will be examed by vascular access surgeon at 2 and 4 weeks after surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Duplex ultrasonography</intervention_name>
    <arm_group_label>Duplex</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  end stage renal disease

          -  newly formed hemodialysis access with native vein

          -  20~70 years

        Exclusion Criteria:

          -  hemodialysis access surgery with ePTFE graft

          -  hemodialysis access surgery with basilic vein transposition

          -  hemodialysis access surgery with brachial vein transposition

          -  cephalic vein &lt; 2.5mm in diameter

          -  radial artery diameter &lt;2.0mm in radiocephalic arteriovenous fistula
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sang-Il Min, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 10, 2012</study_first_submitted>
  <study_first_submitted_qc>May 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2012</study_first_posted>
  <last_update_submitted>May 25, 2015</last_update_submitted>
  <last_update_submitted_qc>May 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>duplex study</keyword>
  <keyword>hemodialysis access</keyword>
  <keyword>maturation rate</keyword>
  <keyword>endovascular intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

